Tominaga M, Fujiyama K, Hoshino T, Tanaka Y, Takeuchi T, Honda M, Mokuda O, Ikeda T, Mashiba H
First Department of Internal Medicine, Tottori University School of Medicine, Yonago, Japan.
Horm Metab Res. 1989 Aug;21(8):438-40. doi: 10.1055/s-2007-1009256.
Urinary N-acetyl-beta-D-glucosaminidase (NAG) was measured in patients with hyperthyroidism. The value of urinary NAG in these patients was higher than that in normal subjects and diabetic patients without diabetic nephropathy. This high level of urinary NAG in patients with hyperthyroidism decreased to the level of normal subjects after treatment of hyperthyroidism. Why urinary NAG increases in the patients with hyperthyroidism remains unknown. On the occasion of estimating the significance of the high level of urinary NAG, however, the possibility of the existence of hyperthyroidism has to be considered in addition to renal damage or hyperglycemia which have already been found to increase urinary NAG.
对甲状腺功能亢进患者测定了尿N-乙酰-β-D-氨基葡萄糖苷酶(NAG)。这些患者的尿NAG值高于正常人和无糖尿病肾病的糖尿病患者。甲状腺功能亢进患者的这种高水平尿NAG在甲状腺功能亢进治疗后降至正常受试者水平。甲状腺功能亢进患者尿NAG升高的原因尚不清楚。然而,在评估高水平尿NAG的意义时,除了已经发现会增加尿NAG的肾损害或高血糖外,还必须考虑存在甲状腺功能亢进的可能性。